Haisco Pharmaceutical Group Co., Ltd.

This study tested whether a new tablet called HSK39297 could help patients with a rare blood disease called PNH who still have low red blood cell counts (anemia) despite being on standard antibody therapy. The goal was to see if the tablet could safely raise hemoglobin levels eno…

This completed Phase 3 trial tested if a new oral tablet called HSK39297 could work as well as the standard injected drug (eculizumab) for people with a rare blood disease called PNH who had never tried this type of medicine before. The main goal was to see if the pill could safe…

This study tested whether a new oral drug called HSK31679 could improve liver health in people with NASH, a serious form of fatty liver disease that causes scarring. About 186 Chinese adults with confirmed NASH and moderate liver scarring took either the drug or a placebo pill da…

This study aimed to see if a medication called HSK16149 is safe and effective for long-term use in people with peripheral nerve pain. It followed 301 Chinese patients for 52 weeks (one year) who had already taken part in earlier studies of the drug. Researchers tracked side effec…

This study tested whether a new injection called HSK21542 could relieve pain after hip replacement surgery. It compared the new drug to both morphine (a standard painkiller) and a placebo (a dummy treatment) in 161 patients. The main goal was to see if HSK21542 was safe and how w…

This early-stage study tested how eating food affects the way the body absorbs and processes a new drug called HSK47388. Fifteen healthy adults took the drug under different conditions: on an empty stomach, right after a low-fat meal, and with a meal after a delay. The main goal …